Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Table. 1.

Table 1 Binding interaction of emodin (EMO) with EGFR and MAP kinase proteins

Compound- protein interaction Docking scores (kcal/mol) Hydrogen bond amino residues Hydrogen bond length (Å) Other bonding amino residues
EGFR-EMO −8.6 GLU C:400
GLU C:317
2.24
2.91
VAL C:336, ALA C:310
MEK1-EMO −7.3 ALA A:769
GLU A:770
2.77
3.49
VAL A:776, VAL A:780, PRO A:773
MEK2-EMO −9.5 GLN A:157
LEU A:78
ASN A:199
ASP A:212
GLY A:153
2.71
2.46
2.01
2.73
3.76
LEU A:201, ALA A:99, LEU A:78, HIS A:149, VAL A:86
ERK1-EMO −9.1 GLN A:121 2.63 ILE A:47, VAL A:55, LEU A:172, TYR A:52, LYS A:70
ERK2-EMO −8.3 MET A:332
ARG A:69
2.72
2.17
GLU A:333, VAL A:172, ARG A:171
p38-EMO −8.6 GLY A:109
HIS A:106
ALA A:110
ASP A:111
2.56
2.67
2.02
2.72
LEU A:166, VAL A:37, LYS A:52, LEU A:166, ALA A:50
Biomolecules & Therapeutics 2024;32:736~743 https://doi.org/10.4062/biomolther.2024.160
© Biomolecules & Therapeutics